Seamus Fernandez

Q: What is Seamus Fernandez's success rate?

Seamus Fernandez currently has a success rate of 79.98108396652617.

Q: What is the average return of Seamus Fernandez's calls?

Their stock ratings have generated an average return of 35.212284558794714.

Guggenheim | Healthcare

Seamus Fernandez is an analyst from Guggenheim specializing in the Healthcare sector. Ranked #1128 out of 4773 analysts, they have issued 39 stock ratings with a success rate of 79.98% and an average return of 35.21%.

Seamus Fernandez has a well-established track record, with 39 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 79.98% and an average return of 35.21%, underscoring their expertise and ability to identify winning opportunities for investors.

#1128

Out of 4773

Total Ratings

+79.98%

Success Rate

+35.21%

Average Return

Recent Ratings Analysis

AMLX

Buy

Aug 19, 2026

Target

$55.00

Current

$31.62

Performance

-18.08%

Seamus Fernandez rated AMLX as Buy on Aug 19, 2026, setting a price target of 55. The stock has underperformed, dropping 18.08% despite the bullish target of 55.

BMY

Buy

Jul 31, 2026

Target

$75.00

Current

$63.64

Performance

-2.56%

On Jul 31, 2026, BMY was given a Buy rating by Seamus Fernandez, with a target price of 75. The stock traded sideways with a -2.56% move, keeping the bullish thesis unresolved.

LLY

Buy

Jul 13, 2026

Target

$1273.00

Current

$1115.25

Performance

-5.64%

LLY received a Buy rating from Seamus Fernandez on Jul 13, 2026, aiming for 1273. The rating hasn’t played out as hoped, with the stock trading 5.64% below expectations.

SEPN

Buy

Jul 01, 2026

Target

$45.00

Current

$38.51

Performance

11.27%

On Jul 01, 2026, Seamus Fernandez published a Buy outlook on SEPN, with a target of 45. Shares gained 11.27%, underscoring the accuracy of the bullish outlook toward 45.

TENX

Buy

Jun 22, 2026

Target

$40.00

Current

$1.86

Performance

-84.82%

Seamus Fernandez on Jun 22, 2026 assigned TENX a Buy rating, with a price target of 40. The call has struggled to gain traction, with shares losing 84.82%.

AVLN

Buy

May 26, 2026

Target

$80.00

Current

$33.57

Performance

25.73%

On May 26, 2026, Seamus Fernandez reaffirmed AVLN with a Buy rating, targeting 80. The recommendation was supported by strong follow-through as the stock rose from 33.57 to 33.57.

ACRS

Buy

May 05, 2026

Target

$12.00

Current

$5.32

Performance

12.00%

ACRS was rated Buy by Seamus Fernandez on May 05, 2026, with a price objective of 12. A bullish response from the market helped close the gap of 6.68 to the target.

SGMT

Buy

Apr 29, 2026

Target

$25.00

Current

$10.88

Performance

26.51%

On Apr 29, 2026, Seamus Fernandez initiated coverage on SGMT with a Buy rating and target of 25. The stock’s climb of 26.51% since the call highlights the foresight in the rating.

APGE

Buy

Mar 24, 2026

Target

$160.00

Current

$135.07

Performance

85.03%

Seamus Fernandez issued a Buy recommendation for APGE on Mar 24, 2026, price target set at 160. Investors following the Buy call captured upside momentum, with shares now at 135.07.

GENB

Buy

Mar 24, 2026

Target

$30.00

Current

$15.72

Performance

30.67%

On Mar 24, 2026, GENB was evaluated by Seamus Fernandez, who gave a Buy rating and target of 30. This case illustrates how a timely bullish rating can translate into tangible gains of 30.67%.

ARQT

Buy

Feb 27, 2026

Target

$35.00

Current

$23.89

Performance

-11.44%

Seamus Fernandez rated ARQT as Buy on Feb 27, 2026, setting a price target of 35. The stock has underperformed, dropping 11.44% despite the bullish target of 35.

RYTM

Buy

Feb 27, 2026

Target

$143.00

Current

$104.71

Performance

12.92%

On Feb 27, 2026, RYTM was given a Buy rating by Seamus Fernandez, with a target price of 143. The stock rallied 12.92% after the rating, narrowing the gap to the target of 143 and validating the bullish stance.

PCVX

Buy

Feb 02, 2026

Target

$116.00

Current

$59.47

Performance

3.61%

PCVX received a Buy rating from Seamus Fernandez on Feb 02, 2026, aiming for 116. Price action was muted, as shares hovered around 59.47 despite the bullish outlook.

GPCR

Buy

Jan 20, 2026

Target

$140.00

Current

$38.66

Performance

-57.53%

On Jan 20, 2026, Seamus Fernandez published a Buy outlook on GPCR, with a target of 140. Market action contradicted the Buy thesis, as shares slipped to 38.66.

MBX

Buy

Jan 16, 2026

Target

$88.00

Current

$59.02

Performance

45.62%

Seamus Fernandez on Jan 16, 2026 assigned MBX a Buy rating, with a price target of 88. The Buy call aligned well with market performance, producing a gain of 45.62%.

SNY

Hold

Dec 09, 2025

Target

—

Current

$42.77

Performance

-10.58%

On Dec 09, 2025, Seamus Fernandez reaffirmed SNY with a Neutral rating, targeting null. The Hold stance reflected market caution that was later justified.

CDTX

Hold

Nov 18, 2025

Target

—

Current

$221.38

Performance

1.36%

CDTX was rated Neutral by Seamus Fernandez on Nov 18, 2025, with a price objective of null. Flat performance suggests the Hold view was reasonable.

IVA

Buy

Nov 18, 2025

Target

$11.00

Current

$4.02

Performance

-3.83%

On Nov 18, 2025, Seamus Fernandez initiated coverage on IVA with a Buy rating and target of 11. Neutral price movement of -3.83% leaves room for interpretation.

ARCT

Hold

Oct 23, 2025

Target

—

Current

$14.73

Performance

22.75%

Seamus Fernandez issued a Neutral recommendation for ARCT on Oct 23, 2025, price target set at null. A neutral call gave way to stronger-than-expected performance, closing in on null.

VERV

Buy

Mar 25, 2025

Target

—

Current

$11.13

Performance

90.58%

On Mar 25, 2025, VERV was evaluated by Seamus Fernandez, who gave a Buy rating and target of null. This case illustrates how a timely bullish rating can translate into tangible gains of 90.58%.

MTSR

Buy

Feb 25, 2025

Target

$56.00

Current

$70.50

Performance

157.96%

Seamus Fernandez rated MTSR as Buy on Feb 25, 2025, setting a price target of 56. The call has proven timely, with shares rising 157.96% toward the price target of 56.

MLYS

Buy

Feb 24, 2025

Target

—

Current

$28.20

Performance

204.86%

On Feb 24, 2025, MLYS was given a Buy rating by Seamus Fernandez, with a target price of null. The stock rallied 204.86% after the rating, narrowing the gap to the target of null and validating the bullish stance.

HLVX

Hold

Jul 08, 2024

Target

—

Current

$2.09

Performance

27.44%

HLVX received a Neutral rating from Seamus Fernandez on Jul 08, 2024, aiming for null. Investors saw gains of 27.44% that the cautious stance didn’t fully capture.

ALT

Hold

Apr 29, 2024

Target

—

Current

$3.27

Performance

-48.91%

On Apr 29, 2024, Seamus Fernandez published a Neutral outlook on ALT, with a target of null. Weakness in the stock, now at 3.27, supported the conservative rating.

Frequency Asked Questions

Who is Seamus Fernandez?

Seamus Fernandez is an analyst from Guggenheim specializing in the Healthcare sector.

What is Seamus Fernandez's success rate?

Seamus Fernandez currently has a success rate of +79.98%.

How many ratings has Seamus Fernandez issued?

Seamus Fernandez has issued 39 stock ratings so far.

What is the average return of Seamus Fernandez's calls?

Their stock ratings have generated an average return of +35.21%.

What is Seamus Fernandez's ranking?

Seamus Fernandez is ranked #1128 out of 4773 analysts.

What types of ratings does Seamus Fernandez give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Seamus Fernandez?

You can follow Seamus Fernandez by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Seamus Fernandez?

Their latest rating was a Buy on AMLX issued on 2026-08-19.